['prader-willi syndrome']
['dccr', 'placebo']

        Inclusion Criteria:

          -  Children. adolescents and young adults with genetically confirmed Prader-Willi
             syndrome

          -  Ages at ≥ 10 years and ≤ 22 years

          -  Generally healthy as documented by the medical history, physical examination, vital
             sign assessments, 12-lead electrocardiogram (ECG), and clinical laboratory assessments

          -  BMI exceeds the 95th percentile of the age specific BMI value on the CDC BMI charts

          -  Fasting glucose ≤ 126 mg/dL

          -  HbA1c ≤ 6.5 %

        Exclusion Criteria:

          -  Administration of investigational drugs within 1 month prior to Screening Visit

          -  Anticipated requirement for use of prohibited medications

          -  History of allergic reaction or significant intolerance to: diazoxide, thiazides or
             sulfonamides

          -  Anticipate transitions in their care from family home to group home or other similar
             potentially disruptive changes

          -  Congestive heart failure or known compromised cardiac reserve

          -  Any other clinically significant endocrine, cardiovascular, pulmonary, neurological,
             psychiatric, hepatic, gastrointestinal, hematological, renal, or dermatological
             disease interfering with the assessments of the investigational drug, according to the
             Investigator
      